115. 遺伝性周期性四肢麻痺 Disease details / Clinical trials / Drug dev / DR info
臨床試験数 : 1 / 薬物数 : 2 - (DrugBank : 2) / 標的遺伝子数 : 13 - 標的パスウェイ数 : 7
薬物ごとの開発者（Primary Sponsor）、臨床試験情報（抜粋）です。
Acetazolamide
University of Rochester
2008 Phase 1 NCT00839501 United Kingdom;United States;
Potassium
University of Rochester
2008 Phase 1 NCT00839501 United Kingdom;United States;
University of Rochester
2008 Phase 1 NCT00839501 United Kingdom;United States;
Potassium
University of Rochester
2008 Phase 1 NCT00839501 United Kingdom;United States;